Tags

, , , ,

Visikol Founders Seated, from left, Prof. James Simon and Michael Johnson.
Standing, from left, Nick Crider and Tom Villani. Photo by Peter Byron

Visikol Inc., a student-run biotech startup from Rutgers University–New Brunswick that markets a technology platform for use in scientific and medical research, has earned a $500,000 commitment from Foundation Venture Capital Group, which announced its investment yesterday, February 23. Visikol sells a versatile clearing agent, which is a chemical formula that renders tissues transparent, allowing researchers to effectively visualize biological tissues in 3-D, as opposed to the traditional slicing based 2-D visualization approach. This approach saves time, reduces structural damage to samples, and enables more information to be gathered from tissues.

Read the full story here.

Advertisements